Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

The effects of guanfacine on context processing abnormalities in schizotypal personality disorder.

McClure MM, Barch DM, Romero MJ, Minzenberg MJ, Triebwasser J, Harvey PD, Siever LJ.

Biol Psychiatry. 2007 May 15;61(10):1157-60. Epub 2006 Sep 1.

PMID:
16950221
2.

Potential noradrenergic targets for cognitive enhancement in schizophrenia.

Friedman JI, Stewart DG, Gorman JM.

CNS Spectr. 2004 May;9(5):350-5. Review.

PMID:
15115947
3.

Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.

Arnsten AF, Jin LE.

Yale J Biol Med. 2012 Mar;85(1):45-58. Epub 2012 Mar 29. Review.

4.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
5.

Dopamine vs noradrenaline: inverted-U effects and ADHD theories.

Levy F.

Aust N Z J Psychiatry. 2009 Feb;43(2):101-8. doi: 10.1080/00048670802607238. Review.

PMID:
19153917
6.

Schizotypal personality disorder: a current review.

Rosell DR, Futterman SE, McMaster A, Siever LJ.

Curr Psychiatry Rep. 2014 Jul;16(7):452. doi: 10.1007/s11920-014-0452-1. Review.

Supplemental Content

Support Center